Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Melanoma Patients Immunized with Natural DenDritic Cells [Phase 3]
Phase 3 trial evaluating immunization of melanoma patients with natural dendritic cells has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers [Phase 1]
Phase 1 study of cosibelimab (CK-301) as a single-agent therapy in adults with advanced cancers; the trial status is active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors [Phase 2]
Phase 2 study evaluating talimogene laherparepvec (T-VEC) with or without radiotherapy in melanoma and Merkel cell carcinoma (and other soli…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
An observational study in Australia is evaluating adjuvant nivolumab after surgical resection of melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma [Phase 1]
This update reports the completion of a Phase 1 trial evaluating phenformin in combination with a BRAF inhibitor and a MEK inhibitor for pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Study of SEA-CD40 Given With Other Drugs in Cancers [Phase 2]
Phase 2 study of SEA-CD40 in combination with other therapies for melanoma and non-small cell lung cancer has completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating pembrolizumab with standard chemotherapy, tumor-infiltrating lymphocytes, and high- or low-dose aldesleukin in pati…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) [Phase 1, Phase 2]
This document is a completed Phase 1/Phase 2 clinical trial update for CAB-ROR2-ADC evaluating safety and efficacy in non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma [Phase 2]
A Phase 2 study evaluating UV1 vaccination in combination with nivolumab and ipilimumab for malignant melanoma has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes [Phase 2]
Results from a Phase 2 trial evaluating nivolumab in combination with talazoparib in patients with metastatic or unresectable melanoma carry…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma [Phase 1, Phase 2]
Clinical trial update reporting phase 1/2 results for bemcentinib (BGB324) in combination with pembrolizumab or with dabrafenib/trametinib i…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
This completed clinical trial update examines the incidence of melanoma and non-melanoma skin cancers in people with vitiligo, with results …
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2 [Phase 2]
Phase 2 trial evaluating radiotherapy as an immunological booster in patients with metastatic melanoma or metastatic renal cell carcinoma tr…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers [Phase 2]
Phase 2 study evaluating YH003 in combination with toripalimab in patients with melanoma and pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]
Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of Modakafusp Alfa (TAK-573) alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the trial wa…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Dendritic Cell Vaccination in Patients With Advanced Melanoma [Phase 1]
Phase 1 clinical trial evaluating dendritic cell vaccination in patients with advanced melanoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 study assessing safety, tolerability, and preliminary efficacy of CJRB-101 in combination with pembrolizumab in selected advanced …
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT [Phase 1, Phase 2]
Update on a Phase I/IIa PET imaging trial of 68GaNOTA-Anti-MMR-VHH2 for malignant solid tumors, including breast cancer and melanoma; the st…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma [Phase 1]
A phase 1 trial evaluating the combination of ipilimumab and nivolumab for stage III/IV unresectable/metastatic cutaneous melanoma has been …
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study of Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating the combination of TBI-1401(HF10) and ipilimumab in Japanese patients with unresectable or metastatic melanoma ha…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Dietary Intervention in Patients with a History of Melanoma [Phase 1]
A Phase 1 trial evaluating a dietary intervention in patients with a history of melanoma has been terminated; no results are reported in the…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: CD8 Minibody Repeatability Study [Phase 2]
ImaginAb's Phase 2 CD8 minibody repeatability study in melanoma and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Phase IIB TL + YCWP + DC in Melanoma [Phase 2]
A Phase II trial evaluating TL + YCWP + DC in melanoma has completed, and results have been posted.